Research News and Research

RSS

Viruses to treat metastatic cancers

There exists a "type" of cancer that is common yet rarely discussed—metastatic cancer, or cancer that has spread from the part of the body where it originated (the primary tumor) to another (such as lungs, bones or liver). Although much research is being done to combat primary tumors, there still exists a crucial need to find a treatment that can be effective against metastatic cancer, or "mets." Could a virus be the answer that finally beats the mets?

15 Nov 2012

Hospitals directed to step up protections for kidney donors

Addressing long-held concerns about whether organ donors have adequate protections, the country's transplant regulators acted late Monday to require that hospitals thoroughly inform living kidney donors of the risks they face, fully evaluate their medical and psychological suitability, and then track their health for two years after donation.

15 Nov 2012

Novel sensor systems to help older people live independently and safely in their homes

University of Adelaide computer scientists are leading a project to develop novel sensor systems to help older people keep living independently and safely in their own homes.

15 Nov 2012

LanPercept to focus on advanced techniques for studying language and perception

LanPercept, a new Marie Curie Initial Training Network funded through the 7th EU Framework Programme, will develop cutting edge techniques to understand vision-language mapping across the life-span in typically and atypically developing populations. New tools and training software will be tested to help disabled and elderly people negotiate the translation between vision and language.

15 Nov 2012

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner today announced results from a Phase 1 clinical trial of PaxVax's single-dose oral cholera vaccine candidate at the 2012 American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting in Atlanta.

15 Nov 2012

Demand growing for female condoms despite myths

Mary Beth Hastings, vice president of the Center for Health and Gender Equality (CHANGE), writes in the Huffington Post's "Impact" blog that despite "the pervasive myth that no one wants female condoms," "[d]emand is increasing because female condoms provide men and women with something they want: more options when it comes to protecting themselves."

15 Nov 2012

UTHealth awarded $1.9M AHRQ grant to enhance care in hospital emergency departments

Researchers from The University of Texas Health Science Center at Houston (UTHealth) have been awarded a four-year, $1.9 million grant from the Agency for Healthcare Research and Quality (AHRQ) to enhance the care in hospital emergency departments.

15 Nov 2012

Despite modest improvement, premature birth rates cause concern

A new report from the March of Dimes gives the U.S. a 'C' in preterm birth rate reductions.

15 Nov 2012

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.

15 Nov 2012

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Flemish biologists lead by Joris Messens (VIB / Vrije Universiteit Brussel) have discovered that Mycobacterium tuberculosis - the bacterium that causes tuberculosis - has an ingenious defence mechanism against oxygen. This knowledge is important in the search for a treatment for tuberculosis. 9.4 million people are infected with tuberculosis annually and 1.7 million people die as a result.

15 Nov 2012

Colorado's new element in exchange plan: Certainty

Colorado Public Radio's Eric Whitney, working in partnership with Kaiser Health News and NPR, reports: "Most states - especially those with Republican governors and legislatures - have opted to have the federal government create and run their exchanges, which are supposed to start enrolling customers in October 2013 for policies that kick in January 2014.

15 Nov 2012

Age at onset of first menstrual cycle associated with increased BMI, obesity in adulthood

Age at onset of menarche (first menstrual cycle) is associated with increased body mass index (BMI), waist circumference, and overall obesity in adulthood, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

15 Nov 2012

Global health community should save AMFm because it saves lives

The Affordable Medicines Facility-malaria began as a pilot program in 2010 to "provide a 'co-payment' to the manufacturers of [artemisinin-based combination therapies (ACTs)], thereby allowing commercial wholesalers and private or government health services to purchase the drugs at a fraction of the already low negotiated price," Kenneth Arrow, a Nobel laureate in economic sciences in 1972 and an emeritus professor of economics at Stanford University, writes in a New York Times opinion piece.

15 Nov 2012

Potential diagnostic method to identify subset of patients with chronic fatigue syndrome

For the first time, researchers have landed on a potential diagnostic method to identify at least a subset of patients with chronic fatigue syndrome (CFS), a complex disorder with no known definitive cause or cure.

15 Nov 2012

Disclosure of PEPFAR data would improve program's efficiency, quality, accountability

The U.S. government, and in particular U.S. Global AIDS Coordinator Ambassador Eric Goosby, the head of PEPFAR, "have a unique opportunity to make [the program's] money stretch farther and do more good, at very little cost to U.S. taxpayers: release the reams of data that PEPFAR and its contractors have already collected, at substantial cost -- perhaps as much as $500 million each year," Mead Over, a senior fellow at the Center for Global Development (CGD), writes in the Center's "Global Health Policy" blog.

15 Nov 2012

Oscillation in brain activity influences listening process

Naturally, our brain activity waxes and wanes. When listening, this oscillation synchronizes to the sounds we are hearing. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences have found that this influences the way we listen. Hearing abilities also oscillate and depend on the exact timing of one's brain rhythms. This discovery that sound, brain, and behaviour are so intimately coupled will help us to learn more about listening abilities in hearing loss.

15 Nov 2012

As health law's fate becomes more clear, insurers, medical device makers try to stem new taxes

Insurers and medical device makers are planning ad campaigns and intense lobbying to try to stop taxes in the health law from cutting at their bottom lines.

15 Nov 2012

Antibody-coated stents carry increased risk of myocardial infarction and re-operation

If narrowed or blocked coronary vessels have to be widened or opened, a vascular support (stent) is usually inserted. Drug-coated stents are preferred for patients at high risk of renewed narrowing of vessels (restenosis). However, the use of antibody-coated stents has been increasing in recent years. Current studies provide indications that these new antibody-coated stents more frequently lead to myocardial infarction and make re-operation necessary.

15 Nov 2012

Alliance of Medicare providers urge link between payment changes, quality

The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.

15 Nov 2012

Scientists eliminate metastasis in laboratory experiments

In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 (mda-9)/syntenin. More than 1 million cases of skin cancer are diagnosed each year in the U.S., and melanoma is the deadliest form.

15 Nov 2012

Research News and Research

Viruses to treat metastatic cancers

Hospitals directed to step up protections for kidney donors

Novel sensor systems to help older people live independently and safely in their homes

LanPercept to focus on advanced techniques for studying language and perception

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

Demand growing for female condoms despite myths

UTHealth awarded $1.9M AHRQ grant to enhance care in hospital emergency departments

Despite modest improvement, premature birth rates cause concern

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Colorado's new element in exchange plan: Certainty

Age at onset of first menstrual cycle associated with increased BMI, obesity in adulthood

Global health community should save AMFm because it saves lives

Potential diagnostic method to identify subset of patients with chronic fatigue syndrome

Disclosure of PEPFAR data would improve program's efficiency, quality, accountability

Oscillation in brain activity influences listening process

As health law's fate becomes more clear, insurers, medical device makers try to stem new taxes

Antibody-coated stents carry increased risk of myocardial infarction and re-operation

Alliance of Medicare providers urge link between payment changes, quality

Scientists eliminate metastasis in laboratory experiments

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery